– STRI showed effects of nEPS treatment to decrease fibrosis and inflammation of early-, middle-, and late-stage liver cirrhosis animal models verified by ALT level and histological analysis.
– STRI have studied the elimination of liver tumor with nEPS injection of liver tumor animal models.
Cirrhosis is a condition in which the liver does not function properly due to long-term damage. This damage is characterized by the replacement of normal liver tissue with scar tissue.
Cirrhosis is most commonly caused by alcohol, hepatitis B, hepatitis C, and non-alcoholic fatty liver disease.
Cirrhosis affected about 2.8 million people and resulted in 1.3 million deaths in 2015. Of these, alcohol caused 348,000, hepatitis C caused 326,000, and hepatitis B caused 371,000 deaths.
Liver cirrhosis was induced via TAA injection to mouse model and created the cirrhosis mouse model. Afterwards, the nEPS was treated, and as a result, liver tissue was recovered to the normal range.